Sort
59,101 grants matching “hypertension”
Non-Coding Variants of Angiotensinogen Gene and Hypertension
$615,000Ashok Kumar Kumar · New York Medical College · R01 · FY2018 · HL
Non-Coding Variants of Angiotensinogen Gene and Hypertension
$615,000Ashok Kumar Kumar · New York Medical College · R01 · FY2019 · HL
Testing Cerebroprotective Interventions with Rodent Ischemic Stroke Models
$614,987Bingren Hu · University Of California, San Diego · U01 · FY2025 · NS
Estrogen receptor alpha signaling in endothelial cells exacerbates arterial stiffening via upregulation of ENaC in insulin resistant females
$614,943Camila Margarita Manrique Acevedo · University Of Missouri-Columbia · R01 · FY2023 · HL
Metabolic Consequences of Low & High Carbohydrate Diets
$614,939Njeri Karanja · Kaiser Foundation Research Institute · R01 · FY2008 · AT
Neighborhoods and Cardiovascular Risk in a Multiethnic Cohort
$614,892Ana V Diez Roux · University Of Michigan At Ann Arbor · R01 · FY2012 · HL
Novel Peptide Therapeutics for Hypertension
$614,866John C Burnett · Mayo Clinic Rochester · R01 · FY2020 · HL
Novel Peptide Therapeutics for Hypertension
$614,866John C Burnett · Mayo Clinic Rochester · R01 · FY2021 · HL
Effect of dietary approaches on vascular function and blood pressure phenotype in youth
$614,861Tammy McLoughlin Brady · Johns Hopkins University · R56 · FY2018 · HL
CVD GENETIC PREDISPOSITIONS AND GENOMIC SIGNATURES
$614,818Winston C Patterson · Univ Of North Carolina Chapel Hill · P50 · FY2010 · HL
Development of a therapeutic anti-marinobufagenin antibody
$614,813Alexei Bagrov · National Institute On Aging · ZIA · FY2012 · AG
MULTICENTER NETWORK OF MATERNAL FETAL MEDICINE UNITS
$614,777Magee-Women'S Res Inst And Foundation · U10 · FY2001 · HD
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity
$614,697Iris Z Jaffe · Tufts Medical Center · R01 · FY2021 · CA
Self-Management Interventions in Life-Limiting Illness
$614,668James Aaron Tulsky · Duke University · P01 · FY2012 · NR
Mechanisms of right ventricle adaptation to pulmonary hypertension
$614,649Tim Lahm · Indiana University Indianapolis · R56 · FY2017 · HL
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC)
$614,646Mark Lynn Unruh · University Of New Mexico Health Scis Ctr · R01 · FY2023 · DK
Integrate Dynamic System Model and Machine Learning for Calibration-Free Noninvasive ICP
$614,615Xiao Hu · University Of California, San Francisco · R01 · FY2018 · NS
Genetic Modifiers of CF Liver Disease
$614,590Michael R Knowles · Univ Of North Carolina Chapel Hill · R01 · FY2008 · DK
Effect of cell-based therapies on functional, hemodynamic, and histologic outcomes in a porcine model of peripheral arterial disease
$614,558Iraklis Ilias Pipinos · University Of Nebraska Medical Center · R01 · FY2020 · AG
Smooth Muscle Mineralocorticoid Receptors in Vascular Aging and Hypertension
$614,476Iris Z Jaffe · Tufts Medical Center · R01 · FY2014 · HL
Mid-Life Health Inequalities in the Rural South: Risk and Resilience
$614,433William Copeland · University Of Vermont & St Agric College · R01 · FY2024 · AG
Using instrumented everyday gait to predict falls in older adults using the WHS cohort
$614,420Peter Michael Wayne · Brigham And Women'S Hospital · R01 · FY2024 · AG
Pre-clinical Validation of A Novel Protein Drug Candidate for ASH and NASH Treatment
$614,398Zhi-Ren Liu · Georgia State University · R01 · FY2021 · DK
Pre-clinical Validation of A Novel Protein Drug Candidate for ASH and NASH Treatment
$614,398Jenny J Yang · Georgia State University · R01 · FY2022 · DK
Pre-clinical Validation of A Novel Protein Drug Candidate for ASH and NASH Treatment
$614,398Jenny J Yang · Georgia State University · R01 · FY2023 · DK